Skip to content

GE HealthCare Technologies

NASDAQ: GEHC · USD

GE HealthCare Technologies financials

6 charts

Revenue

USD millions

$5,295M
GE HealthCare Technologies Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2023 Q1$4,707M; Change unavailable vs FY 2022 Q4
FY 2023 Q2$4,817M; +2.3% vs FY 2023 Q1
FY 2023 Q3$4,822M; +0.1% vs FY 2023 Q2
FY 2023 Q4$5,206M; +8.0% vs FY 2023 Q3
FY 2024 Q1$4,650M; −10.7% vs FY 2023 Q4
FY 2024 Q2$4,839M; +4.1% vs FY 2024 Q1
FY 2024 Q3$4,863M; +0.5% vs FY 2024 Q2
FY 2024 Q4$5,319M; +9.4% vs FY 2024 Q3
FY 2025 Q1$4,777M; −10.2% vs FY 2024 Q4
FY 2025 Q2$5,007M; +4.8% vs FY 2025 Q1
FY 2025 Q3$5,143M; +2.7% vs FY 2025 Q2
FY 2025 Q4$5,698M; +10.8% vs FY 2025 Q3
FY 2026 Q1$5,131M; −10.0% vs FY 2025 Q4
FY 2026 Q2$5,295M; +3.2% vs FY 2026 Q1
Mar 31, 2023 through Sep 25, 2026

Free cash flow

USD millions

$68M
GE HealthCare Technologies Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2023 Q1$325M; Change unavailable vs FY 2022 Q4
FY 2023 Q2$-137M; −142.2% vs FY 2023 Q1
FY 2023 Q3$570M; +516.1% vs FY 2023 Q2
FY 2023 Q4$956M; +67.7% vs FY 2023 Q3
FY 2024 Q1$274M; −71.3% vs FY 2023 Q4
FY 2024 Q2$-183M; −166.8% vs FY 2024 Q1
FY 2024 Q3Unavailable; Change unavailable vs FY 2024 Q2
FY 2024 Q4$811M; Change unavailable vs FY 2024 Q3
FY 2025 Q1$98M; −87.9% vs FY 2024 Q4
FY 2025 Q2$8M; −91.8% vs FY 2025 Q1
FY 2025 Q3Unavailable; Change unavailable vs FY 2025 Q2
FY 2025 Q4$916M; Change unavailable vs FY 2025 Q3
FY 2026 Q1$112M; −87.8% vs FY 2025 Q4
FY 2026 Q2$68M; −39.3% vs FY 2026 Q1

Net margin

%

10.59%
GE HealthCare Technologies Net margin. Reported fiscal history.
Fiscal period%
FY 2023 Q17.9%
FY 2023 Q28.68%
FY 2023 Q37.78%
FY 2023 Q47.74%
FY 2024 Q18.04%
FY 2024 Q28.84%
FY 2024 Q39.66%
FY 2024 Q413.56%
FY 2025 Q111.81%
FY 2025 Q29.71%
FY 2025 Q38.67%
FY 2025 Q410.34%
FY 2026 Q17.58%
FY 2026 Q210.59%

P/E

× · TTM · Daily

15.24×
GE HealthCare Technologies P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2024-10-3123.94×2024-09-30
2024-11-2922.8×2024-09-30
2024-12-3121.42×2024-09-30
2025-01-3124.2×2024-09-30
2025-02-2820.12×2024-12-31
2025-03-3118.59×2024-12-31
2025-04-3016.2×2024-12-31
2025-05-3014.83×2025-03-31
2025-06-3015.57×2025-03-31
2025-07-3115×2025-03-31
2025-08-2915.5×2025-03-31
2025-09-3015.79×2025-03-31
2025-10-3115.76×2025-03-31
2025-11-2816.82×2025-03-31
2025-12-3117.25×2025-03-31
2026-01-3016.6×2025-03-31
2026-02-2718.52×2025-12-31
2026-03-3115.64×2025-12-31
2026-04-3013.37×2025-12-31
2026-05-2913.7×2025-12-31
2026-06-3014.07×2025-12-31
2026-07-3115.56×2026-06-30
2026-08-3116.29×2026-06-30
2026-09-2515.24×2026-06-30

ROIC

% · Annual / TTM

11.3%
GE HealthCare Technologies ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q4—
FY 2024 Q111.33%
FY 2024 Q210.85%
FY 2024 Q311.85%
FY 2024 Q413.39%
FY 2025 Q113.55%
FY 2025 Q213.31%
FY 2025 Q313.1%
FY 2025 Q413.25%
FY 2026 Q111.25%
FY 2026 Q211.3%

Capital allocation

% of tracked cash uses

$316M
GE HealthCare Technologies capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2023 Q152.96% · $143M47.04% · $127MUnavailable0% · $0M0% · $0M100% · $270M
FY 2023 Q267.31% · $70M19.23% · $20MUnavailable13.46% · $14M0% · $0M100% · $104M
FY 2023 Q385.11% · $80M0% · $0MUnavailable14.89% · $14M0% · $0M100% · $94M
FY 2023 Q487.85% · $94M0% · $0MUnavailable12.15% · $13MUnavailable100% · $107M
FY 2024 Q191.19% · $145M0% · $0MUnavailable8.81% · $14MUnavailable100% · $159M
FY 2024 Q218.99% · $64M76.85% · $259MUnavailable4.15% · $14MUnavailable100% · $337M
FY 2024 Q387.38% · $90M0% · $0M0% · $0M12.62% · $13MUnavailable100% · $103M
FY 2024 Q460% · $102M31.76% · $54M0% · $0M8.24% · $14MUnavailable100% · $170M
FY 2025 Q134.78% · $152M61.56% · $269M0% · $0M3.66% · $16MUnavailable100% · $437M
FY 2025 Q240.57% · $86M4.72% · $10M47.17% · $100M7.55% · $16MUnavailable100% · $212M
FY 2025 Q348.67% · $110M0% · $0M44.25% · $100M7.08% · $16MUnavailable100% · $226M
FY 2025 Q453.82% · $134M39.76% · $99M0% · $0M6.43% · $16MUnavailable100% · $249M
FY 2026 Q16.87% · $178M88.65% · $2,297M3.86% · $100M0.62% · $16MUnavailable100% · $2,591M
FY 2026 Q231.65% · $100MUnavailable63.29% · $200M5.06% · $16MUnavailable100% · $316M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for GE HealthCare Technologies.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources